Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Penn Medicine: “Black Women Face Three-Fold Increased Risk of Triple Negative Breast Cancers.” Breastcancer.org: “Triple-Negative Breast Cancer Deadlier for Black Women, Partially Due to ...

More information: Melinda Magna et al, RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer, npj Breast Cancer (2023). DOI: 10.1038/s41523-023-00564-9 Journal ...

In this webinar, you’ll learn how triple-negative breast cancer (TNBC) is different from other subtypes of breast cancer, and how doctors are treating it more effectively with new therapies.

Tara M. Friebel-Klingner et al, Risk factors for breast cancer subtypes among Black women undergoing screening mammography, Breast Cancer Research and Treatment (2021). DOI: 10.1007/s10549-021-06340-2 ...

A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming. Oncogene , 2022; DOI: 10.1038 ...

The bispecific compound, called BNT-327, had positive results in patients with triple negative breast cancer. If future trials on the bispecific produce more positive data, ...

Triple-negative breast cancer lacks the expression of estrogen, progesterone and HER2 receptors, and so it makes it unresponsive for standard hormonal therapies targeting HER2.

Triple negative breast cancer meets its match BBOX1 enzyme could serve as a drug target for the deadly subset of breast cancer Date: July 22, 2020 ...

Truth is, she never thought she'd live to see her 40th birthday or meet her son. Siobhan was diagnosed with triple-negative breast cancer when she was 32 -- and while she was nine weeks pregnant.

Our lab is a group of cancer biologists and neuroscientists who focus on the relationship between cancer and the nervous system. I study triple negative breast cancer, an aggressive type of breast ...